Eupraxia Pharmaceuticals, Inc. · TSX:EPRX
Morgan C. Frank reported a 7.70% stake in Eupraxia Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 12, 2026
Morgan C. Frank reported a 7.70% stake in Eupraxia Pharmaceuticals, Inc., 4,015,248 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).
- Stake
- 7.70%
- Shares
- 4,015,248
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Manchester Management Company, LLC | 7.40% | 3,830,869 |
| Manchester Management PR, LLC | 7.40% | 3,830,869 |
| Manchester Explorer, L.P. | 7.10% | 3,707,942 |
| James E. Besser | 7.60% | 3,969,162 |
| Morgan C. Frank | 7.70% | 4,015,248 |
Source
Related
- Eupraxia Pharmaceuticals, Inc.
- James E. Besser
- Eupraxia Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · James E. Besser · Aug 13, 2026
- Schedule 13G/A · James E. Besser · Feb 17, 2026
- Schedule 13G · James E. Besser · Nov 13, 2025
- Schedule 13D/A · Joseph S. Freedman · Mar 16, 2026
- Schedule 13G/A · Robert Disbrow · Nov 14, 2025
- Schedule 13G · Beutel, Goodman & Co Ltd. · Nov 14, 2025
- Schedule 13D/A · Joseph S. Freedman · Sep 26, 2025